This week the FDA approved a first of its kind drug that targets cancers' genes.
The cancer drug Keytruda, is an immunotherapy drug.
This is a milestone — the first time a cancer drug has received approval for targeting a particular biomarker rather than a location in the body.
Read more HERE
Photo Credit: Getty Images